← All trials
NCT05154591
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2018
- Primary completion
- Feb 28, 2021
- Completion date
- Feb 28, 2021
- First posted
- Dec 13, 2021
- Last posted
- Dec 13, 2021
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Autonomous University of NicaraguaLead sponsor
- University of MiamiOverall official - principal investigator
- University of Texas, GalvestonStudy director
- Wake Forest UniversityOverall official - principal investigator
- government of nicaraguaCollaborator
- National Autonomous University of NicaraguaSponsor investigator
- National Autonomous University of NicaraguaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.